Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Loredana Balacescu"'
Autor:
Oana Baldasici, Olga Soritau, Andrei Roman, Carmen Lisencu, Simona Visan, Laura Maja, Bogdan Pop, Bogdan Fetica, Andrei Cismaru, Laurian Vlase, Loredana Balacescu, Ovidiu Balacescu, Aman Russom, Oana Tudoran
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Background Cancer stem-like cells (CSCs) have been extensively researched as the primary drivers of therapy resistance and tumor relapse in patients with breast cancer. However, due to lack of specific molecular markers, increased phenotypic
Externí odkaz:
https://doaj.org/article/0078d5c4c5e44c268eece64cafeb7586
Autor:
Alexandra Gherman, Dinu Bolundut, Radu Ecea, Loredana Balacescu, Sebastian Curcean, Constantin Dina, Ovidiu Balacescu, Calin Cainap
Publikováno v:
Medicina, Vol 60, Iss 3, p 397 (2024)
Currently, only a limited set of molecular traits are utilized to direct treatment for metastatic CRC (mCRC). The molecular classification of CRC depicts tumor heterogeneity based on gene expression patterns and aids in comprehending the biological c
Externí odkaz:
https://doaj.org/article/589c330f226942ab87e98d88f39e731d
Publikováno v:
Life, Vol 13, Iss 12, p 2300 (2023)
(1) Background: Following the results of RAINBOW and REGARD trials, ramucirumab was approved as the standard second-line treatment for patients with advanced or metastatic gastric or gastroesophageal junction (GEJ) cancer, alone or in combination wit
Externí odkaz:
https://doaj.org/article/bd59da45669248a28c0be529a99e3576
Autor:
Alexandra Gherman, Loredana Balacescu, Calin Popa, Calin Cainap, Catalin Vlad, Simona S. Cainap, Ovidiu Balacescu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10622 (2023)
The status of predictive biomarkers in metastatic colorectal cancer is currently underdeveloped. Our study aimed to investigate the predictive value of six circulating exosomal miRNAs derived from plasma (miR-92a-3p, miR-143-3p, miR-146a-5p, miR-221-
Externí odkaz:
https://doaj.org/article/e72fc153e6404236b4071e320618b9fb
Autor:
Simona Visan, Olga Soritau, Corina Tatomir, Oana Baldasici, Loredana Balacescu, Ovidiu Balacescu, Patricia Muntean, Cristina Gherasim, Adela Pintea
Publikováno v:
Molecules, Vol 28, Iss 11, p 4486 (2023)
In women, breast cancer is the most commonly diagnosed cancer (11.7% of total cases) and the leading cause of cancer death (6.9%) worldwide. Bioactive dietary components such as Sea buckthorn berries are known for their high carotenoid content, which
Externí odkaz:
https://doaj.org/article/3fd1259a39944e298044919e4f4c5565
Autor:
Oana Baldasici, Loredana Balacescu, Daniel Cruceriu, Andrei Roman, Carmen Lisencu, Bogdan Fetica, Simona Visan, Andrei Cismaru, Ancuta Jurj, Lucian Barbu-Tudoran, Valentina Pileczki, Laurian Vlase, Oana Tudoran, Ovidiu Balacescu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12625 (2022)
Neo-adjuvant therapy (NAT) is increasingly used in the clinic for the treatment of breast cancer (BC). Pathological response to NAT has been associated with improved patients’ survival; however, the current techniques employed for assessing the tum
Externí odkaz:
https://doaj.org/article/76509f5f1d2a4f75955ad30bdb8a0568
Autor:
Lorena Alexandra Lisencu, Andrei Roman, Simona Visan, Eduard-Alexandru Bonci, Andrei Pașca, Emilia Grigorescu, Elena Mustea, Andrei Cismaru, Alexandru Irimie, Cosmin Lisencu, Loredana Balacescu, Ovidiu Balacescu, Oana Tudoran
Publikováno v:
Medicina, Vol 58, Iss 10, p 1494 (2022)
Background and Objectives: Prediction of response to therapy remains a continuing challenge in treating breast cancer, especially for identifying molecular tissue markers that best characterize resistant tumours. Microribonucleic acids (miRNA), known
Externí odkaz:
https://doaj.org/article/68e06fc3970a4f97a98a873b9212518d
Autor:
Oana Baldasici, Valentina Pileczki, Daniel Cruceriu, Laura Ioana Gavrilas, Oana Tudoran, Loredana Balacescu, Laurian Vlase, Ovidiu Balacescu
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 9371 (2022)
Metastasis represents the most important cause of breast cancer-associated mortality. Even for early diagnosed stages, the risk of metastasis is significantly high and predicts a grim outcome for the patient. Nowadays, efforts are made for identifyin
Externí odkaz:
https://doaj.org/article/2629b00b5dce43b8a2efd79e62ab8320
Autor:
Daniel Sur, Loredana Balacescu, Simona S. Cainap, Simona Visan, Laura Pop, Claudia Burz, Andrei Havasi, Rares Buiga, Calin Cainap, Alexandru Irimie, Ovidiu Balacescu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
MicroRNAs (miRNAs), a class of small non-coding RNAs represent potential biomarkers for colorectal cancer (CRC). The study hypothesized that miRNAs associated with liver metastases may also contribute to assessing treatment response when associated t
Externí odkaz:
https://doaj.org/article/e71b9bbcac494ed9ac10623732919f6d
Autor:
Calin Cainap, Rodica Ana Ungur, Ovidiu-Vasile Bochis, Patriciu Achimas, Catalin Vlad, Andrei Havasi, Andreea Vidrean, Anca Farcas, Tiberiu Tat, Alexandra Gherman, Andra Piciu, Madalina Bota, Anne-Marie Constantin, Laura Ancuta Pop, Dana Maniu, Ovidiu Crisan, Cosmin Vasile Cioban, Ovidiu Balacescu, Ovidiu Coza, Loredana Balacescu, Monica Mihaela Marta, Eleonora Dronca, Simona Cainap
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0248922 (2021)
Colorectal cancer remains one of the most frequent malignancies (third place at both genders) worldwide in the last decade, owing to significant changes in modern dietary habits. Approximately half of the patients develop metastases during the course
Externí odkaz:
https://doaj.org/article/e9890793171d49abb67d4df27f2aeaf7